Cargando…

Surgical treatment of metastatic diseases to the lung

INTRODUCTION: The problem of treating secondary cancer is very controversial. Huge progress in its treatment began in the 1970s with the introduction of chemotherapy. In the surgical aspect Pastorino’s work published in 1997 was a milestone. To this day, most authors cite its research results. AIM:...

Descripción completa

Detalles Bibliográficos
Autores principales: Religioni, Jarosław, Orłowski, Tadeusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379223/
https://www.ncbi.nlm.nih.gov/pubmed/32728365
http://dx.doi.org/10.5114/kitp.2020.97254
_version_ 1783562592064634880
author Religioni, Jarosław
Orłowski, Tadeusz
author_facet Religioni, Jarosław
Orłowski, Tadeusz
author_sort Religioni, Jarosław
collection PubMed
description INTRODUCTION: The problem of treating secondary cancer is very controversial. Huge progress in its treatment began in the 1970s with the introduction of chemotherapy. In the surgical aspect Pastorino’s work published in 1997 was a milestone. To this day, most authors cite its research results. AIM: The task is to answer the question what tactics to follow in the surgical treatment of patients with secondary cancer affecting the respiratory system. MATERIAL AND METHODS: Retrospective studies were conducted on a group of 577 patients. Men prevailed slightly. The average age was 56 years. Surgical access used in the vast majority of cases was anterolateral thoracotomy. Wedge resection was the most common scope of surgery. Lymph nodes were not removed as standard. Single and multifactorial statistical surveys were conducted (Kaplan-Meier estimator and multifactorial Cox regression analysis). RESULTS: A total of 1,058 operations were performed during which 1889 metastases were removed. Negative tissue margins were obtained in 90.4%. The median survival was 47 months. Complications occurred in 76 patients, which constituted 7.1% of performed procedures. There were 3 perioperative deaths. CONCLUSIONS: It was found that the factors negatively affecting survival were lack of radicalism, size of the metastasis > 3 cm, and number of metastases > 1. The factors positively influencing survival were a longer time than primary surgery and a greater number of operations. Histological diagnosis differentiated patient survival.
format Online
Article
Text
id pubmed-7379223
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-73792232020-07-28 Surgical treatment of metastatic diseases to the lung Religioni, Jarosław Orłowski, Tadeusz Kardiochir Torakochirurgia Pol Original Paper INTRODUCTION: The problem of treating secondary cancer is very controversial. Huge progress in its treatment began in the 1970s with the introduction of chemotherapy. In the surgical aspect Pastorino’s work published in 1997 was a milestone. To this day, most authors cite its research results. AIM: The task is to answer the question what tactics to follow in the surgical treatment of patients with secondary cancer affecting the respiratory system. MATERIAL AND METHODS: Retrospective studies were conducted on a group of 577 patients. Men prevailed slightly. The average age was 56 years. Surgical access used in the vast majority of cases was anterolateral thoracotomy. Wedge resection was the most common scope of surgery. Lymph nodes were not removed as standard. Single and multifactorial statistical surveys were conducted (Kaplan-Meier estimator and multifactorial Cox regression analysis). RESULTS: A total of 1,058 operations were performed during which 1889 metastases were removed. Negative tissue margins were obtained in 90.4%. The median survival was 47 months. Complications occurred in 76 patients, which constituted 7.1% of performed procedures. There were 3 perioperative deaths. CONCLUSIONS: It was found that the factors negatively affecting survival were lack of radicalism, size of the metastasis > 3 cm, and number of metastases > 1. The factors positively influencing survival were a longer time than primary surgery and a greater number of operations. Histological diagnosis differentiated patient survival. Termedia Publishing House 2020-07-20 2020-06 /pmc/articles/PMC7379223/ /pubmed/32728365 http://dx.doi.org/10.5114/kitp.2020.97254 Text en Copyright © 2020 Polish Society of Cardiothoracic Surgeons (Polskie Towarzystwo KardioTorakochirurgów) and the editors of the Polish Journal of Cardio-Thoracic Surgery (Kardiochirurgia i Torakochirurgia Polska) http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/)
spellingShingle Original Paper
Religioni, Jarosław
Orłowski, Tadeusz
Surgical treatment of metastatic diseases to the lung
title Surgical treatment of metastatic diseases to the lung
title_full Surgical treatment of metastatic diseases to the lung
title_fullStr Surgical treatment of metastatic diseases to the lung
title_full_unstemmed Surgical treatment of metastatic diseases to the lung
title_short Surgical treatment of metastatic diseases to the lung
title_sort surgical treatment of metastatic diseases to the lung
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379223/
https://www.ncbi.nlm.nih.gov/pubmed/32728365
http://dx.doi.org/10.5114/kitp.2020.97254
work_keys_str_mv AT religionijarosław surgicaltreatmentofmetastaticdiseasestothelung
AT orłowskitadeusz surgicaltreatmentofmetastaticdiseasestothelung